Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationThe MHRA and the Department of Health in Northern Ireland, working closely with the HRA, consulted on a set of proposals to update, improve and strengthen the UK legislation that underpins the regulation of clinical trials. Having analysed over 2000 responses received, we will now take forward legislation to reform of the UK clinical trials regulatory framework that will: Ensure patients and their safety are at the focus of all clinical trials and bring the benefits of clinical trials to everyone Create a proportionate and flexible regulatory environment Cement the UK as a destination for international trials Provide a framework that is streamlined, agile and responsive to innovation This package of changes will deliver on our vision for a more proportionate, streamlined, flexible and effective clinical research environment, putting patients at the heart and the UK at the forefront of innovative regulation for clinical trials.
The legislative changes will help to make the UK one of the best countries in the world to conduct clinical research for patients and researchers.
The HRA and the MHRA are committed to enabling the highest quality health and social care research which can benefit the whole UK population. We are working together to help researchers increase the diversity of people taking part in research in the UK and we will set out our expectations in future guidance.
The 115 page ECA Guide was launched and first published at the ECA Live Online Conference GMP-compliant Equipment Design in November 2022 - and can now be downloaded free of charge.
With the aim to enhance communication with the CTIS user community, this regular CTIS newsflash provides key updates on CTIS and links to useful reference materials.
Key information for patients, consumers and healthcare professionals - Published monthly by the European Medicines Agency
FDA issued final guidance.
Update to the Life Sciences Council Joint Statement on Medical Devices Regulatory Reform.
MHRA fees for 2022 - 2023 are remaining the same as 2021 - 2022.
List updated 14 March 2023